✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Asker Healthcare Group AB

Common Name
Asker Healthcare Group
Country
Sweden
Sector
Healthcare
Industry
Medical Distribution
Employees
4,505
Ticker
ASKER
Exchange
NASDAQ STOCKHOLM AB
Description
Asker Healthcare Group AB is a leading provider of medical products and solutions driving progress across the European healthcare sector. The company partners with caregivers and patients by building ...

Asker Healthcare Group's GHG Emissions Data Preview

In 2024, Asker Healthcare Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Asker Healthcare Group has also provided a category-level breakdown for 9 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)202420232022
2021 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
0000000
Total Scope 2
Market-Based
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
0000000
Location-Based
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
0000000
Total Scope 3
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
0000000
Limited Data Preview
You are viewing a limited preview of Asker Healthcare Group’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2021, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=ASKER&reporting_period=2024"

Verified Sources Behind Asker Healthcare Group’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Asker Healthcare Group’s data sources below and access millions more through our Disclosure Search.

a. Asker Healthcare Group's Annual Report 2024

Insights into Asker Healthcare Group's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Asker Healthcare Group amounted to 7,173 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Asker Healthcare Group decreased by 4.33%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Asker Healthcare Group's Scope 1 Emissions Over Time

20212023202401.5 k3 k4.5 k6 ktCO2e-12%-5%
  • Total Scope 1
  • Year-over-Year Change

What are Asker Healthcare Group's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Asker Healthcare Group were 4,343 metric tons of CO₂ equivalent (tCO₂e).a

Has Asker Healthcare Group reduced its Scope 1 emissions over time?

Since 2021, Asker Healthcare Group's Scope 1 emissions have decreased by 16.58%, reflecting a declining long-term trend in Scope 1 emissions over time.a

Compared to the previous year (2023), Asker Healthcare Group's Scope 1 emissions decreased by 4.99%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a

What are Asker Healthcare Group's Scope 2 emissions?

In 2024, Asker Healthcare Group reported Scope 2 greenhouse gas (GHG) emissions of 978 tCO₂e using the market-based method and 2,830 tCO₂e using the location-based method.a

Has Asker Healthcare Group reduced its Scope 2 emissions over time?

Since 2021, Asker Healthcare Group's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have increased by 10.42%, reflecting a rising long-term trend in Scope 2 emissions over time.a

Compared to the previous year (2023), Asker Healthcare Group's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Asker Healthcare Group's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does Asker Healthcare Group use for Scope 2 reporting?

In 2024, Asker Healthcare Group reported its Scope 2 emissions using the market-based method and using the location-based method.a

Asker Healthcare Group's Scope 2 Emissions Over Time

20212023202407501.5 k2.25 k3 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Asker Healthcare Group's Value Chain Emissions

In 2024, Asker Healthcare Group reported 544,038 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2024 disclosure of Asker Healthcare Group includes a breakdown across 9 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

Asker Healthcare Group's Scope 3 Emissions Over Time

2021202320240150 k300 k450 k600 ktCO2e+20%+15%
  • Total Scope 3
  • Year-over-Year Change

What are Asker Healthcare Group's Scope 3 emissions?

In 2024, Asker Healthcare Group reported total Scope 3 emissions of 544,038 metric tons of CO₂ equivalent (tCO₂e).a

Approximately 97.33% of these emissions originated from upstream activities such as purchased goods and capital goods, while 2.67% came from downstream activities like product use, distribution, and end-of-life treatment.a

Has Asker Healthcare Group reduced its Scope 3 emissions over time?

Since 2021, Asker Healthcare Group's Scope 3 emissions have increased by 37.51%, reflecting a rising long-term trend in Scope 3 emissions over time.a

Compared to the previous year (2023), Asker Healthcare Group's Scope 3 emissions increased by 14.72%, suggesting that the company faced challenges in reducing emissions across its value chain.a

What categories of Scope 3 emissions does Asker Healthcare Group disclose?

In 2024, Asker Healthcare Group reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol.a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of Asker Healthcare Group's Scope 3 emissions?

In 2024, the largest contributors to Asker Healthcare Group's Scope 3 emissions were:a

  • Purchased Goods and Services (Cat. 1): 503,418 tCO₂e (92.53%)
  • End-of-Life Treatment of Sold Products (Cat. 12): 12,215 tCO₂e (2.25%)
  • Upstream Transportation and Distribution (Cat. 4): 9,967 tCO₂e (1.83%)

Asker Healthcare Group's Scope 3 Emissions by Categories

End-of-LifeTreatment of SoldProducts (Cat. 12)(2.2%)Purchased Goods andServices (Cat. 1)(92.5%)UpstreamTransportation andDistribution(Cat. 4)(1.8%)

Insights into Asker Healthcare Group’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Asker Healthcare Group reported Scope 1 greenhouse gas (GHG) emissions of 4,343 tCO₂e and total revenues of USD 1,363 millions. This translates into an emissions intensity of 3.19 tCO₂e per millions USD.a

Asker Healthcare Group's Scope 1 Emissions Intensity Compared to Peers

0.2520010,000500,000Scope 1 Emissions (tCO2e)5050010,000100,0001,000,000Revenues (Millions of USD)CBJMCAs OneYear: 2024Scope 1: 165 tCO2eRevenue: $M 631Scope 1 Intensity: 0.26 tCO2e/$MCCCencoraYear: 2024Scope 1: 135,087 tCO2eRevenue: $M 293,987Scope 1 Intensity: 0.46 tCO2e/$MMedicoverYear: 2024Scope 1: 6,020 tCO2eRevenue: $M 24,216Scope 1 Intensity: 0.25 tCO2e/$MSectraYear: 2024Scope 1: 148 tCO2eRevenue: $M 269Scope 1 Intensity: 0.55 tCO2e/$MArjoYear: 2024Scope 1: 20,385 tCO2eRevenue: $M 1,025Scope 1 Intensity: 19.89 tCO2e/$MBiogaiaYear: 2024Scope 1: 73 tCO2eRevenue: $M 129Scope 1 Intensity: 0.57 tCO2e/$MSigma HealthcareYear: 2024Scope 1: 8 tCO2eRevenue: $M 3,028Scope 1 Intensity: 0.00 tCO2e/$MVitrolifeYear: 2024Scope 1: 742 tCO2eRevenue: $M 327Scope 1 Intensity: 2.27 tCO2e/$MApotea SverigeYear: 2024Scope 1: 0 tCO2eRevenue: $M 500Scope 1 Intensity: 0.00 tCO2e/$MElektaYear: 2025Scope 1: 5,007 tCO2eRevenue: $M 1,865Scope 1 Intensity: 2.69 tCO2e/$MBICO GroupYear: 2024Scope 1: 37 tCO2eRevenue: $M 177Scope 1 Intensity: 0.21 tCO2e/$MMcKessonYear: 2025Scope 1: 72,223 tCO2eRevenue: $M 359,140Scope 1 Intensity: 0.20 tCO2e/$MUnipharYear: 2024Scope 1: 2,833 tCO2eRevenue: $M 2,883Scope 1 Intensity: 0.98 tCO2e/$MGalenicaYear: 2024Scope 1: 6,546 tCO2eRevenue: $M 4,330Scope 1 Intensity: 1.51 tCO2e/$MAmplifonYear: 2024Scope 1: 7,507 tCO2eRevenue: $M 2,507Scope 1 Intensity: 2.99 tCO2e/$MBBBaiyunshan Pharmaceutical HoldingsYear: 2024Scope 1: 34,043 tCO2eRevenue: $M 10,276Scope 1 Intensity: 3.31 tCO2e/$MJJJointown Pharmaceutical GroupYear: 2024Scope 1: 36,924 tCO2eRevenue: $M 20,801Scope 1 Intensity: 1.78 tCO2e/$MAlfresa HoldingsYear: 2025Scope 1: 31,360 tCO2eRevenue: $M 19,746Scope 1 Intensity: 1.59 tCO2e/$MMMMedipal HoldingsYear: 2024Scope 1: 31,081 tCO2eRevenue: $M 23,500Scope 1 Intensity: 1.32 tCO2e/$MCM HospitalarYear: 2024Scope 1: 8,154 tCO2eRevenue: $M 1,875Scope 1 Intensity: 4.35 tCO2e/$MCCChina National MedicinesYear: 2024Scope 1: 907 tCO2eRevenue: $M 6,934Scope 1 Intensity: 0.13 tCO2e/$MEBOS GroupYear: 2025Scope 1: 3,343 tCO2eRevenue: $M 8,055Scope 1 Intensity: 0.42 tCO2e/$MAsker Healthcare GroupYear: 2024Scope 1: 4,343 tCO2eRevenue: $M 1,363Scope 1 Intensity: 3.19 tCO2e/$M

How does Asker Healthcare Group's GHG emissions intensity compare to its peers?

In 2024, Asker Healthcare Group reported a Scope 1 emissions intensity of 3.19 tCO₂e per millions USD. Compared to the peer group median of 0.77, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does Asker Healthcare Group rank on GHG emissions intensity within its industry?

In 2024, Asker Healthcare Group ranked 20 out of 22 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places Asker Healthcare Group among the least efficient performers, with one of the highest emissions intensities in its sector.a

Insights into Asker Healthcare Group's Total Carbon Footprint

In 2024, Asker Healthcare Group reported a total carbon footprint of 551,211 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 14.43% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a

The largest contributor to Asker Healthcare Group's total carbon footprint was Scope 3 emissions, accounting for 98.7% of the company's total carbon footprint, followed by Scope 1 emissions at 0.79%.a

Want Full Access to Asker Healthcare Group's GHG Emissions Dataset?
Start 30-Day Free Trial